Dysfunctional uterine bleeding cost-effectiveness of therapy

Jump to navigation Jump to search

Dysfunctional uterine bleeding Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Dysfunctional uterine bleeding from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Dysfunctional uterine bleeding cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Dysfunctional uterine bleeding cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Dysfunctional uterine bleeding cost-effectiveness of therapy

CDC on Dysfunctional uterine bleeding cost-effectiveness of therapy

Dysfunctional uterine bleeding cost-effectiveness of therapy in the news

Blogs on Dysfunctional uterine bleeding cost-effectiveness of therapy

Directions to Hospitals Treating Dysfunctional uterine bleeding

Risk calculators and risk factors for Dysfunctional uterine bleeding cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Arooj Naz, M.B.B.S

Overview

Women are subjected to increased financial burden to treat underlying abnormal uterine bleeding. Annually, they loose USD $2,000.00 on account of work absences. Hormonal medications range from USD $172.00 for contraceptive pills, USD $930.00 for levonorgestrel IUD and upwards of USD $30,000.00 for hysterectomies.

Cost-effectiveness of Therapy

Cost related to the treatment of abnormal uterine bleeding depends on the underlying cause. Studies show that women in the United States have lost more than USD $2,000.00 annually due cyclical pain and resultant work absences. The annual cost of fibroids was calculated to be USD $4.1-$9.4 billion.[1]

Treatment Costs for Dysfunctional Uterine Bleeding
Treatment modality Cost-effectiveness
Contraceptive Pill[2] USD $172.00
Levonorgestrel IUD[3] USD $930.00; Copper-T IUD is a cheaper IUD but would exacerbate vaginal bleeding and is not recommended (USD $647.00)
Abdominal Hysterectomy[4] USD $43,622.00; costs vary depending on operative time, and length of stay
Vaginal Hysterectomy[4] USD $31,934.00; costs vary depending on operative time, and length of stay
Laparoscopic Hysterectomy[4] USD $38,312.00; costs vary depending on operative time, and length of stay
Robotic Hysterectomy[4] USD $49,526.00; costs vary depending on operative time, and length of stay

References

  1. Whitaker L, Critchley HO (2016). "Abnormal uterine bleeding". Best Pract Res Clin Obstet Gynaecol. 34 ( ): 54–65. doi:10.1016/j.bpobgyn.2015.11.012. PMC 4970656. PMID 26803558.
  2. Torres A, Forrest JD (1983). "The costs of contraception". Fam Plann Perspect. 15 (2): 70–2. PMID 6671479.
  3. Trussell J, Lalla AM, Doan QV, Reyes E, Pinto L, Gricar J (2009). "Cost effectiveness of contraceptives in the United States". Contraception. 79 (1): 5–14. doi:10.1016/j.contraception.2008.08.003. PMC 3638200. PMID 19041435.
  4. 4.0 4.1 4.2 4.3 Wright KN, Jonsdottir GM, Jorgensen S, Shah N, Einarsson JI (2012). "Costs and outcomes of abdominal, vaginal, laparoscopic and robotic hysterectomies". JSLS. 16 (4): 519–24. doi:10.4293/108680812X13462882736736. PMC 3558885. PMID 23484557.

Template:WH Template:WS